Medtronic MiniMed insulin pumps are being recalled due to an issue that can lead to incorrect dosing. The affected pumps include the MiniMed 630G and MiniMed 670G. The recall affects 322,055 devices.

The FDA announced an international Class 1 recall of 322,005 Medtronic’s MiniMed 600 Series Insulin Pumps that can cause the user to receive an incorrect amount of insulin. According to the recall ...

Medtronic is recalling more than 322,000 MiniMed insulin pumps because a faulty locking mechanism may cause incorrect dosing. The flaw could prove fatal to the type 1 diabetics who rely on the devices ...

Closed-loop insulin pump therapy is the most advanced technology available to date for type 1 diabetes. It's "theoretically brilliant, and it's the future," said co-lead investigator Gregory Goodwin, ...

WASHINGTON--Patients with type 1 diabetes who use Medtronic's MiniMedTM 670G insulin pump system are able to maintain blood glucose levels in the targeted range over 71% of the time, according to a ...

Medtronic says real-world data show its MiniMed 670G glucose management system increased time in range for people with diabetes. Medtronic has announced clinical outcomes for the MiniMed 670G system, ...

Retainer rings on its MiniMed 630G and MiniMed 670G insulin pumps have been breaking, which can lead to a health hazard for users. The retaining ring is responsible for locking the insulin reservoir ...

Editor’s Note: A few weeks ago, a Type 1 diabetes patient authored a blog post about why she didn’t want to switch to Medtronic’s MiniMed 670G billed as the industry’s first hybrid closed-loop insulin ...

Medtronic plcMDT announced that the FDA has approved a new arm indication for the Guardian Sensor 3 continuous glucose monitor (CGM) used with the MiniMed 670G insulin pump. Notably, the Guardian ...

The MiniMed 780G system (Medtronic) advanced hybrid closed-loop insulin delivery system aimed at simplifying the management of type 1 diabetes is now available in the UK for people aged 7 to 80 years.

Medtronic plcMDT recently announced FDA approval for its MiniMed 670G system for patients with type 1 diabetes between seven and 13 years of age. Notably, the approval was based on positive data from ...

The Food and Drug Administration surprised—and pleased—the diabetes medical community this year when they approved a new, high-tech insulin delivery system for Type I diabetics six months sooner than ...